Devices and methods for heart valve treatment
View Patent ↗Devices and methods for treating heart valves include members that assist the valve in closing during at least a portion of the cardiac cycle. Such devices include members configured to alter the shape of a valve annulus, reposition at least one papillary muscle, and/or plug an orifice of the valve so as to provide a coaptation surface for the valve leaflets.
1. A method for treating a heart valve of a patient, comprising:
advancing a catheter having a lumen into a heart chamber, wherein a heart valve treatment device is disposed within the lumen of the catheter, the heart valve treatment device including:
an elongate member having a first end;
an anchoring mechanism secured to the first end of the elongate member; and
a plug member;
disposing the heart valve treatment device proximate the heart valve;
securing the anchoring mechanism to heart tissue; and
positioning the plug member within an orifice of the heart valve so that leaflets of the heart valve contact the plug member during a portion of the cardiac cycle.
2. The method of claim 1 , wherein the plug member is expandable.
3. The method of claim 1 , wherein the elongate member has a second end, and the plug member is secured to the second end.
4. The method of claim 1 , wherein the step of advancing a catheter having a lumen into a heart chamber includes advancing the catheter through a blood vessel, a right atrium, and a left atrium.
5. The method of claim 4 , wherein the blood vessel is a vena cava, and the heart valve is a mitral valve.
6. The method of claim 1 , wherein the heart tissue is a wall of a ventricle.
7. The method of claim 1 , wherein the method does not include placing the patient on cardiopulmonary bypass.
8. A method for reducing regurgitation of a mitral valve of a patient, comprising:
endovascularly advancing a catheter having a lumen to an orifice of the mitral valve, wherein a plug device is disposed within the lumen of the catheter, the plug device including an expandable mitral valve plug and an elongate member;
disposing a portion of the elongate member within a left ventricle of the heart;
securing an end of the elongate member to heart tissue; and
positioning the expandable mitral valve plug within the orifice of the mitral valve so that leaflets of the mitral valve engage the mitral valve plug during a portion of the cardiac cycle, the expandable mitral valve plug being secured to the elongate member.
9. The method of claim 8 , wherein endovascularly advancing a catheter having a lumen to an orifice of the mitral valve includes advancing the catheter through a blood vessel, a right atrium, and a left atrium.
10. The method of claim 9 , wherein the blood vessel is a vena cava.
11. The method of claim 8 , wherein the heart tissue includes a wall of the left ventricle.
12. The method of claim 8 , wherein the portion of the cardiac cycle is systole.
13. The method of claim 8 , wherein method does not include placing the patient on cardiopulmonary bypass.
14. The method of claim 8 , wherein the step of securing an end of the elongate member to heart tissue includes attaching the end of the elongate member to an anchor.
15. A method for reducing regurgitation of a mitral valve of a patient's heart, comprising:
advancing a catheter including a mitral valve plug device through a patient's vena cava, a right atrium, and into a left atrium, the mitral valve plug device including an elongate member having a first end portion and a second end portion, the second end portion including a plug secured thereto;
securing the first end portion of the elongate member to a septal wall with an anchor pad;
disposing the second end portion of the elongate member proximate the mitral valve; and
positioning the plug within an orifice of the mitral valve, such that leaflets of the mitral valve engage the plug during a portion of a cardiac cycle.
16. The method of claim 15 , wherein the plug is expandable.
17. The method of claim 15 , wherein the plug includes a coating.
18. The method of claim 17 , wherein the coating includes an agent configured to promote endothelial growth.
19. The method of claim 16 , wherein the plug is inflatable.
20. The method of claim 15 , wherein the plug includes a first configuration when disposed within the catheter.
21. The method of claim 20 , wherein the plug changes to a second configuration different from the first configuration when removed from the catheter.
22. The method of claim 15 , wherein the plug includes an elongate configuration when positioned within the orifice of the mitral valve.
23. The method of claim 15 , wherein the plug engages leaflets of the mitral valve only during the portion of the cardiac cycle.
24. The method of claim 23 , wherein the portion of the cardiac cycle is systole.